Results 281 to 290 of about 327,068 (394)

Real-World Effectiveness and Safety of Mepolizumab in Severe Eosinophilic Asthma: Insights From the Korean Severe Asthma Registry (KoSAR). [PDF]

Allergy Asthma Immunol Res
Park SY, Lee D, Kim JH, Lee Y, Ban GY, Sim DW, Kwon JW, Kim SR, Song WJ, Park HW, Chang YS, Koh YI, Lee BJ, Park HS, Cho YS, Kim SH.   +15 more
europepmc   +1 more source

Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma. [PDF]

Front Immunol, 2023
Esposito I, Kontra I, Giacomassi C, Manou-Stathopoulou S, Brown J, Stratton R, Verykokou G, Buccafusca R, Stevens M, Nissim A, Lewis MJ, Pfeffer PE.   +11 more
europepmc   +1 more source

Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience

, 2022
Reyhan Yıldız, Yavuz Selim Demirel, Dilşad Mungan, Ömür Aydın, Betül Ayşe Sin, Meltem Ağca, Sevim Bavbek   +6 more
openalex   +1 more source

Dad's legacy: Epigenetic reprogramming and paternal inflammatory memory in offspring health

Journal of Internal Medicine, Volume 298, Issue 1, Page 16-30, July 2025.
Abstract Over the past decade, numerous reports have highlighted intergenerational and even transgenerational epigenetic effects resulting from parental exposure to diets, toxins, and stress. In many cases, these parentally induced phenotypes do not seem to confer an obvious benefit, making it challenging to understand the evolutionary drivers behind ...
Shamila D. Alipoor, Parisa Norouzitallab, Anita Öst, Maria Lerm   +3 more
wiley   +1 more source

Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study. [PDF]

J Clin Med
Quarato CMI, Tondo P, Lacedonia D, Soccio P, Pescatore D, Baccellieri ML, Lepore G, Foschino Barbaro MP, Scioscia G.   +8 more
europepmc   +1 more source

Decreased expression of airway epithelial Axl is associated with eosinophilic inflammation in severe asthma

, 2022
Koji Itakura, Naoya Fujino, Yosuke Kamide, Ikuo Saito, Mitsuhiro Yamada, Koji Okutomo, Yoko Tsukita, Takuya Saito, Tomohiro Ichikawa, Tadahisa Numakura, Yorihiko Kyogoku, Hiroyuki Aizawa, Yoshinao Ono, Shuichiro Matsumoto, Tracy Hussell, Masami Taniguchi, Masakazu Ichinose, Hisatoshi Sugiura   +17 more
openalex   +1 more source

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment. [PDF]

World Allergy Organ J
Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Bhavsar P, Adcock IM, Chung KF, Kim TB.   +28 more
europepmc   +1 more source

Randomised controlled trial of azithromycin in smokers with asthma [PDF]

, 2013
Anderson, K., Cameron, E.J., Chaudhuri, R., Donnelly, I., Evans, T.J., Gallacher, K., Greenlaw, N., Jolly, L., Mair, F., McSharry, C., Morrison, D., Spears, M., Thomson, N.C, Weir, C.J.   +13 more
core   +2 more sources

Development of Eosinophilic Granulomatosis With Polyangiitis Despite Anti–Interleukin‐5 Receptor Therapy: The First Case of Bilateral Central Retinal Artery Occlusion During Benralizumab Treatment

ACR Open Rheumatology, Volume 7, Issue 6, June 2025.
Here, we describe a rare presentation of eosinophilic granulomatosis with polyangiitis (EGPA) under benralizumab therapy manifesting as bilateral central retinal artery occlusion (CRAO). The patient, a 61‐year‐old man with chronic eosinophilic rhinosinusitis and severe asthma, experienced sudden bilateral visual loss and transient amaurosis ...
Elena Treppo, Lucia Finocchio, Benedetta Fazzi, Maria Pillon, Luca Quartuccio   +4 more
wiley   +1 more source

Stellate Ganglion Block and Bilateral Sympathectomy for Recurrent Coronary Vasospasm Secondary to Severe Eosinophilic Asthma. [PDF]

JACC Case Rep
Wu KY, Mao R, Butler C, Gouda P, Alhulaimi N, Parab R, Dicken BJ, Khandekar S, Graham M, Bainey KR.   +9 more
europepmc   +1 more source